PetMed Express (PETS)
(Delayed Data from NSDQ)
$4.11 USD
0.00 (0.00%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $4.10 -0.01 (-0.24%) 6:18 PM ET
3-Hold of 5 3
A Value F Growth C Momentum B VGM
Income Statements
Fiscal Year end for PetMed Express, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | NA | 257 | 273 | 309 | 284 |
Cost Of Goods | NA | 186 | 195 | 219 | 203 |
Gross Profit | NA | 71 | 78 | 90 | 81 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 72 | 52 | 52 | 50 |
Income After Depreciation & Amortization | 0 | -1 | 26 | 38 | 31 |
Non-Operating Income | NA | 3 | 1 | 2 | 3 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | 2 | 27 | 39 | 34 |
Income Taxes | NA | 1 | 6 | 9 | 8 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 0 | 21 | 31 | 26 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 0 | 21 | 31 | 26 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 2 | 28 | 40 | 33 |
Depreciation & Amortization (Cash Flow) | NA | 4 | 3 | 2 | 2 |
Income After Depreciation & Amortization | 0 | -1 | 26 | 38 | 31 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | NA | 20.34 | 20.36 | 20.12 | 20.06 |
Diluted EPS Before Non-Recurring Items | -99,999.00 | 0.37 | 1.08 | 1.52 | 1.29 |
Diluted Net EPS (GAAP) | -99,999.00 | 0.01 | 1.04 | 1.52 | 1.29 |
Fiscal Year end for PetMed Express, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | 71.00 | 78.24 | 62.41 |
Cost Of Goods | NA | NA | 50.94 | 55.72 | 45.02 |
Gross Profit | NA | NA | 20.06 | 22.53 | 17.38 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 20.50 | 24.66 | 24.49 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | -0.44 | -2.13 | -7.11 |
Non-Operating Income | NA | NA | 0.82 | 1.13 | 1.08 |
Interest Expense | NA | NA | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | NA | 0.38 | -1.00 | -6.03 |
Income Taxes | NA | NA | 0.45 | -0.12 | -0.93 |
Minority Interest | NA | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | NA | -0.07 | -0.89 | -5.10 |
Extras & Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | -0.07 | -0.89 | -5.10 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 20.38 | 20.33 | 20.34 |
Diluted EPS Before Non-Recurring Items | -99,999.00 | -99,999.00 | 0.00 | 0.00 | 0.04 |
Diluted Net EPS (GAAP) | -99,999.00 | -99,999.00 | 0.00 | -0.04 | -0.26 |